N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I
- PMID: 18499743
- DOI: 10.1124/jpet.108.139295
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I
Erratum in
- J Pharmacol Exp Ther. 2011 Jul;338(1):410
Abstract
The transient receptor potential (TRP) vanilloid 4 (TRPV4) member of the TRP superfamily has recently been implicated in numerous physiological processes. In this study, we describe a small molecule TRPV4 channel activator, (N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), which we have used as a valuable tool in investigating the role of TRPV4 in the urinary bladder. GSK1016790A elicited Ca2+ influx in mouse and human TRPV4-expressing human embryonic kidney (HEK) cells (EC50 values of 18 and 2.1 nM, respectively), and it evoked a dose-dependent activation of TRPV4 whole-cell currents at concentrations above 1 nM. In contrast, the TRPV4 activator 4alpha-phorbol 12,13-didecanoate (4alpha-PDD) was 300-fold less potent than GSK1016790A in activating TRPV4 currents. TRPV4 mRNA was detected in urinary bladder smooth muscle (UBSM) and urothelium of TRPV4+/+ mouse bladders. Western blotting and immunohistochemistry demonstrated protein expression in both the UBSM and urothelium that was absent in TRPV4-/- bladders. TRPV4 activation with GSK1016790A contracted TRPV4+/+ mouse bladders in vitro, both in the presence and absence of the urothelium, an effect that was undetected in TRPV4-/- bladders. Consistent with the effects on TRPV4 HEK whole-cell currents, 4alpha-PDD demonstrated a weak ability to contract bladder strips compared with GSK1016790A. In vivo, urodynamics in TRPV4+/+ and TRPV4-/- mice revealed an enhanced bladder capacity in the TRPV4-/- mice. Infusion of GSK1016790A into the bladders of TRPV4+/+ mice induced bladder overactivity with no effect in TRPV4-/- mice. Overall TRPV4 plays an important role in urinary bladder function that includes an ability to contract the bladder as a result of the expression of TRPV4 in the UBSM.
Similar articles
-
Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat.J Pharmacol Exp Ther. 2007 Oct;323(1):227-35. doi: 10.1124/jpet.107.125435. Epub 2007 Jul 17. J Pharmacol Exp Ther. 2007. PMID: 17636010
-
Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.J Pharmacol Exp Ther. 2008 Aug;326(2):443-52. doi: 10.1124/jpet.107.134551. Epub 2008 May 22. J Pharmacol Exp Ther. 2008. PMID: 18499744
-
Intravesical Activation of the Cation Channel TRPV4 Improves Bladder Function in a Rat Model for Detrusor Underactivity.Eur Urol. 2018 Sep;74(3):336-345. doi: 10.1016/j.eururo.2018.05.020. Epub 2018 Jun 3. Eur Urol. 2018. PMID: 29875065
-
The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.BJU Int. 2010 Oct;106(8):1114-27. doi: 10.1111/j.1464-410X.2010.09650.x. BJU Int. 2010. PMID: 21156013 Review.
-
TRPV4.Handb Exp Pharmacol. 2007;(179):189-205. doi: 10.1007/978-3-540-34891-7_11. Handb Exp Pharmacol. 2007. PMID: 17217058 Review.
Cited by
-
Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes.Mar Drugs. 2020 Oct 18;18(10):519. doi: 10.3390/md18100519. Mar Drugs. 2020. PMID: 33081023 Free PMC article.
-
Piezo1-induced durotaxis of pancreatic stellate cells depends on TRPC1 and TRPV4 channels.bioRxiv [Preprint]. 2024 Apr 15:2023.12.22.572956. doi: 10.1101/2023.12.22.572956. bioRxiv. 2024. PMID: 38187663 Free PMC article. Preprint.
-
Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction.Investig Clin Urol. 2022 May;63(3):309-315. doi: 10.4111/icu.20210418. Epub 2022 Mar 23. Investig Clin Urol. 2022. PMID: 35437956 Free PMC article.
-
Transient receptor potential vanilloid 4 channels as therapeutic targets in diabetes and diabetes-related complications.J Diabetes Investig. 2020 Jul;11(4):757-769. doi: 10.1111/jdi.13244. Epub 2020 Apr 16. J Diabetes Investig. 2020. PMID: 32129549 Free PMC article. Review.
-
TRPV4: physiological role and therapeutic potential in respiratory diseases.Naunyn Schmiedebergs Arch Pharmacol. 2015 Apr;388(4):421-36. doi: 10.1007/s00210-014-1058-1. Epub 2014 Oct 24. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 25342095 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous